Publications
LuViva as a Screening Tool in Cervical Neoplasia: Analysis on 58 Women in Costa Rica– Crónicas Científicas, Salazar-Mora, R; et al, 3 July 2019
The Performance of Multimodal Hyperspectral Spectroscopy in the Detection of Precancerous Cervical Lesions – Journal of Physics, Trahmono et al 2017
Multimodal Hyperspectroscopy as a Triage Test for Cervical Neoplasia: Pivotal Clinical Trial Results – Gynecologic Oncology, Leo Twiggs, MD, et al, 1 July 2013 – LuViva® Advanced Cervical Scan
Is Colposcopy and/or Biopsy Always Necessary? – Hospital Healthcare Europe 2013 – LuViva® Advanced Cervical Scan
Comparison of Human Papilloma Virus Testing and Spectroscopy Combined With Cervical Cytology for the Detection of High-grade Cervical Neoplasia – Journal of Lower Genital Tract Disease, April 2007 – LuViva® Advanced Cervical Scan
Spectroscopic Imaging as a Triage Test for Cervical Disease: A Prospective Multicenter Clinical Trial – Journal of Lower Genital Tract Disease, January 2006 – LuViva® Advanced Cervical Scan
Women’s Responses to Cervical Interrogation by Fluorescent and Reflective Spectroscopy – Journal of Lower Genital Tract Disease, April 2003 – LuViva® Advanced Cervical Scan
Multimodal Hyperspectral Imaging for the Noninvasive Diagnosis of Cervical Neoplasia – Journal of Lower Genital Tract Disease, October 2001 – LuViva® Advanced Cervical Scan
Oral Presentations:
XXIX FIGO World Congress 2015 Abnormal Spectroscopy Scans May Presage Persistent or Progressive Cervical Dysplasia – Leo B. Twiggs, M.D. – LuViva® Advanced Cervical Scan
Turkish Society of Gynecology Oncology Congress (TSGO) 2014 – Biophotonic Detection of Cervical Dysplasia: The Transition from Clinical Trials to Real World Use – Leo B. Twiggs, M.D. – LuViva® Advanced Cervical Scan
European Congress of Obstetrics and Gynaecology (EBCOG) 2010 – Multimodal Spectroscopy as a Triage Test for Women at Risk for cervical neoplasia: Results of a 1,607 subject pivotal trial– Nahida Chakhtoura, M.D. – LuViva® Advanced Cervical Scan
American Society for Colposcopy and Cervical Pathology (ASCCP) 2010 – Multimodal Spectroscopy as a Triage Test for Women at Risk for cervical neoplasia: Results of a 1,607 subject pivotal trial – Leo B. Twiggs, M.D. – LuViva® Advanced Cervical Scan
American Society for Colposcopy and Cervical Pathology (ASCCP) 2010 – Multimodal Spectroscopy as a Triage Test for Women at Risk for cervical neoplasia: Results of follow up data– Nahida Chakhtoura, M.D. – LuViva® Advanced Cervical Scan
INCOLO 2007 – Quantitative Optical Spectroscopy of the Uterine Cervix: A cost effective way to detect and manage cervical disease – Nahida Chakhtoura, M.D. – LuViva® Advanced Cervical Scan
American Society for Colposcopy and Cervical Pathology (ASCCP) 2006 – Comparison of HPV Testing and spectroscopy combined with cytology for the detection of high-grade cervical Neoplasia – Claudia Werner, M.D. – LuViva® Advanced Cervical Scan
European Research Organisation on Genital Infection and Neoplasia (EUROGIN) 2003 – Multimodal spectroscopic imaging of the cervix for triaging patients to colposcopy – Leo B. Twiggs, M.D. – LuViva® Advanced Cervical Scan
Poster Presentations:
Society of Gynecology and Obstetrics of Nigeria 2014 – Results of LuViva Test with Comparisons to Other Tests – Cytology, HPV, VIA and Histopathology – Principal Investigator for cervical cancer in Nigeria: Professor Isaac Adewole, Co-Principal Investigator: Dr. O. Awolude
Society of Gynecology and Obstetrics of Nigeria 2014 – Cervical Screening with LuViva Machice for Early Detection of Cervical Dysplasia: Experience from Ekiti State, Nigeria – Professor Olusola B. Fasubaa et al
International Federation of Cervical Pathology and Colposcopy (IFCPC) 2014 – LuViva Cervical Scan as a triage test to reduce unnecessary colposcopy and biopsy – James Bentley, MBChB FRCSC– LuViva® Advanced Cervical Scan
American Society for Colposcopy and Cervical Pathology (ASCCP) 2012 – Preliminary Assessment of cervical spectroscopy for primary screening of moderate and high grade cervical dysplasia – Lisa C. Flowers, M.D. – LuViva® Advanced Cervical Scan
American Congress of Obstetricians and Gynecologists (ACOG) 2012 – Optimal Combination of cervical spectroscopy with cytology and HPV: Implications for Clinic efficiency – Marc L. Winter, M.D. – LuViva® Advanced Cervical Scan
International Society for Optics and Photonics, Photonics West 2011 – Identifying Constituent Spectra Sources in Multispectral Images to Quantify and Locate Cervical Neoplasia– LuViva® Advanced Cervical Scan
American Society for Colposcopy and Cervical Pathology (ASCCP) 2010 – Multimodal spectroscopy as a triage test for women at risk for cervical neoplasia: experience with a low cost commercial prototype – Marc L. Winter, M.D. – LuViva® Advanced Cervical Scan
American Society for Colposcopy and Cervical Pathology (ASCCP) 2010 – Multimodal spectroscopy as a triage test for women at risk for cervical neoplasia: Histopathology review procedures and results – Ed J. Wilkinson, M.D. – LuViva® Advanced Cervical Scan
American Society for Colposcopy and Cervical Pathology (ASCCP) 2010 – Multimodal spectroscopy as a triage test for women at risk for cervical neoplasia: Results for Adolescent Patients – Lisa C. Flowers, M.D. – LuViva® Advanced Cervical Scan
American Society for Colposcopy and Cervical Pathology (ASCCP) 2008 – Quantitative Optical spectroscopy offers a cost effective method for diagnosing cervical cancer
American Society for Colposcopy and Cervical Pathology (ASCCP) 2006 – Spectroscopic Imaging as a triage test for cervical disease: A prospective multicenter clinical trial – Timothy DeSantis, M.D. – LuViva® Advanced Cervical Scan